OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intergenically Spliced Chimeric RNAs in Cancer
Yuemeng Jia, Zhongqiu Xie, Hui Li
Trends in cancer (2016) Vol. 2, Iss. 9, pp. 475-484
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Genomic basis for RNA alterations in cancer
Claudia Calabrese, Natalie R. Davidson, Deniz Demircioğlu, et al.
Nature (2020) Vol. 578, Iss. 7793, pp. 129-136
Open Access | Times Cited: 362

Gene Fusions in Thyroid Cancer
V. D. Yakushina, Larisa V. Lerner, А. В. Лавров
Thyroid (2017) Vol. 28, Iss. 2, pp. 158-167
Closed Access | Times Cited: 110

CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data
Liqing Tian, Yongjin Li, Michael N. Edmonson, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 98

SETD5 Regulates Chromatin Methylation State and Preserves Global Transcriptional Fidelity during Brain Development and Neuronal Wiring
Alessandro Sessa, Luca Fagnocchi, Giuseppina Mastrototaro, et al.
Neuron (2019) Vol. 104, Iss. 2, pp. 271-289.e13
Open Access | Times Cited: 92

Evaluation of Salivary Exosomal Chimeric GOLM1-NAA35 RNA as a Potential Biomarker in Esophageal Carcinoma
Yusheng Lin, Hongmei Dong, Weilun Deng, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 10, pp. 3035-3045
Open Access | Times Cited: 82

Post-Translational Peptide Splicing and T Cell Responses
Michele Mishto, Juliane Liepe
Trends in Immunology (2017) Vol. 38, Iss. 12, pp. 904-915
Open Access | Times Cited: 66

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets
Yang Pan, Kathryn E. Kadash-Edmondson, Robert Wang, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 268-282
Open Access | Times Cited: 53

Chimeric RNAs in cancer and normal physiology
Katarzyna Chwalenia, Loryn Facemire, Hui Li
Wiley Interdisciplinary Reviews - RNA (2017) Vol. 8, Iss. 6
Closed Access | Times Cited: 62

Living Organisms Author Their Read-Write Genomes in Evolution
James A. Shapiro
Biology (2017) Vol. 6, Iss. 4, pp. 42-42
Open Access | Times Cited: 62

SLC45A3-ELK4 functions as a long non-coding chimeric RNA
Fujun Qin, Yanmei Zhang, Jia Liu, et al.
Cancer Letters (2017) Vol. 404, pp. 53-61
Closed Access | Times Cited: 53

The UGTome: The expanding diversity of UDP glycosyltransferases and its impact on small molecule metabolism
Dong Hu, Julie-Ann Hulin, Pramod C. Nair, et al.
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107414-107414
Closed Access | Times Cited: 44

Extracellular vesicles-based vaccines: Emerging immunotherapies against cancer
Yuhua Meng, Zhimeng Yao, Xiurong Ke, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 438-459
Open Access | Times Cited: 6

Overcoming cancer drug-resistance calls for novel strategies targeting abnormal alternative splicing
Ji Zhang, Xinyu Xu, Hong‐Wei Deng, et al.
Pharmacology & Therapeutics (2024) Vol. 261, pp. 108697-108697
Closed Access | Times Cited: 5

Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts
Neetha Nanoth Vellichirammal, Abrar Albahrani, Jasjit K. Banwait, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 1379-1398
Open Access | Times Cited: 37

Dysregulation of cancer genes by recurrent intergenic fusions
Jae Won Yun, Lixing Yang, Hye-Young Park, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 35

Recurrent fusion RNA DUS4L-BCAP29 in non-cancer human tissues and cells
Yue Tang, Fujun Qin, A. Q. Liu, et al.
Oncotarget (2017) Vol. 8, Iss. 19, pp. 31415-31423
Open Access | Times Cited: 38

Computational analysis of sense-antisense chimeric transcripts reveals their potential regulatory features and the landscape of expression in human cells
Sumit Mukherjee, Rajesh Detroja, Deepak Balamurali, et al.
NAR Genomics and Bioinformatics (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 24

Fusion‐associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance
Suet Kee Loo, Megan E. Yates, Sichun Yang, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 261-273
Open Access | Times Cited: 19

RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)
Jacqueline Rehn, Chelsea Mayoh, Susan L. Heatley, et al.
PLoS Genetics (2022) Vol. 18, Iss. 10, pp. e1010300-e1010300
Open Access | Times Cited: 19

Chimerism: A whole new perspective in gene regulation
Gayatri G Chitale, Swati Kulkarni, Sharmila A. Bapat
Biochimica et Biophysica Acta (BBA) - General Subjects (2025), pp. 130767-130767
Closed Access

Revealing the role of U2AF1 in splicing regulation and chimeric RNA dynamics
Shahid Ullah Khan, Yue Tang, Y. Guo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
Shi Yao, Juan Yuan, Vilma Rraklli, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 5, pp. 2509-2521
Open Access | Times Cited: 22

Identification of the cross-strand chimeric RNAs generated by fusions of bi-directional transcripts
Yuting Wang, Qin Zou, Fajin Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 22

Discovery of clinically relevant fusions in pediatric cancer
Stephanie LaHaye, James Fitch, Kyle Voytovich, et al.
BMC Genomics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top